Multimodal neuroimaging of alcohol use: from acute neurochemical effects to chronic brain network reorganization and precision treatment targets
-
By
-
Rodolfo Ferrando
-
May 11, 2026
-
Clinical Scorecard: Comprehensive Neuroimaging Approaches to Alcohol Consumption: Investigating Immediate Neurochemical Impacts, Long-term Brain Network Changes, and Targeted Treatment Strategies
At a Glance
| Category | Detail |
| Condition | Alcohol Use Disorder (AUD) |
| Key Mechanisms | Neurotoxic and neuroadaptive effects impacting multiple brain systems, including dopaminergic, GABAergic, glutamatergic, and opioid signaling. |
| Target Population | Individuals with alcohol use disorder, including adolescents and older adults. |
| Care Setting | Clinical and research settings utilizing multimodal neuroimaging techniques. |
Key Highlights
- Neuroimaging reveals acute and chronic effects of alcohol on brain structure and function.
- Adolescent alcohol use is linked to deviations in brain maturation and increased vulnerability.
- Longitudinal imaging can assess recovery during abstinence and predict clinical outcomes.
- Distinct imaging patterns characterize neurological syndromes related to prolonged alcohol use.
- Individual differences in brain structure and function correlate with AUD risk and treatment response.
Guideline-Based Recommendations
Diagnosis
- Utilize structural MRI to detect neurological syndromes associated with alcohol use.
Management
- Implement targeted treatment strategies based on neuroimaging markers of vulnerability.
Monitoring & Follow-up
- Employ longitudinal imaging to monitor structural and functional recovery during abstinence.
Risks
- Consider the impact of chronic alcohol exposure on brain atrophy and cognitive impairment.
Patient & Prescribing Data
Individuals diagnosed with alcohol use disorder, including those at familial or genetic risk.
Neuroimaging can inform treatment response and guide precision medicine approaches.
Clinical Best Practices
- Integrate multimodal neuroimaging in the assessment and treatment of AUD.
- Focus on individual differences in neuroimaging to tailor interventions.
- Monitor neuroimaging markers to predict relapse and treatment outcomes.
Related Resources & Content